Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications
MarketWatchPaywall
Read Full Article at MarketWatch →Ad Slot — In-Article (728x90)
The Danish company Novo says U. S. -based Lilly isn’t including the most up-to-date clinical information about its drugs.
This is a summary. For the full story, read the original article at MarketWatch.
Original source: MarketWatch